In last trading session, Core Laboratories Inc (NYSE:CLB) saw 0.76 million shares changing hands with its beta currently measuring 1.47. Company’s recent per share price level of $11.86 trading at $0.25 or 2.15% at ring of the bell on the day assigns it a market valuation of $553.89M. That closing price of CLB’s stock is at a discount of -111.89% from its 52-week high price of $25.13 and is indicating a premium of 14.5% from its 52-week low price of $10.14. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.67 million shares which gives us an average trading volume of 444.58K if we extend that period to 3-months.

For Core Laboratories Inc (CLB), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 3.17. Splitting up the data highlights that, out of 4 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.2 in the current quarter.

Core Laboratories Inc (NYSE:CLB) trade information

Upright in the green during last session for gaining 2.15%, in the last five days CLB remained trading in the red while hitting it’s week-highest on Thursday, 04/24/25 when the stock touched $11.86 price level, adding 10.15% to its value on the day. Core Laboratories Inc’s shares saw a change of -31.48% in year-to-date performance and have moved -6.02% in past 5-day. Core Laboratories Inc (NYSE:CLB) showed a performance of -22.94% in past 30-days. Number of shares sold short was 6.61 million shares which calculate 16.72 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 26 to the stock, which implies a rise of 54.38% to its current value. Analysts have been projecting 17 as a low price target for the stock while placing it at a high target of 32. It follows that stock’s current price would drop -43.34% in reaching the projected high whereas dropping to the targeted low would mean a loss of -43.34% for stock’s current value.

Core Laboratories Inc (CLB) estimates and forecasts

This year revenue growth is estimated to fall -0.09% from the last financial year’s standing.

4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 130.03M for the same. And 4 analysts are in estimates of company making revenue of 133.93M in the next quarter. Company posted 130.58M and 134.4M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -20.53% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -8.63% while estimates for its earnings growth in next 5 years are of 9.62%.

CLB Dividends

Core Laboratories Inc is more likely to be releasing its next quarterly report on 2025-Apr-22 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 0.34%, the share has a forward dividend of 0.04 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 0.83%.

Core Laboratories Inc (NYSE:CLB)’s Major holders

Insiders are in possession of 1.01% of company’s total shares while institution are holding 112.95 percent of that, with stock having share float percentage of 114.10%. Investors also watch the number of corporate investors in a company very closely, which is 112.95% institutions for Core Laboratories Inc that are currently holding shares of the company. ARIEL INVESTMENTS, LLC is the top institutional holder at CLB for having 10.29 million shares of worth $208.83 million. And as of 2024-06-30, it was holding 21.9415 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 7.8 million shares on 2024-06-30. The number of shares represents firm’s hold over 16.6241 of outstanding shares, having a total worth of $158.22 million.

On the other hand, Ariel Investment Trust-Ariel Fund and iShares Trust-iShares Core S&P Small-Cap ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 3.51 shares of worth $41.57 million or 7.51% of the total outstanding shares. The later fund manager was in possession of 2.9 shares on Mar 31, 2025 , making its stake of worth around $34.34 million in the company or a holder of 6.20% of company’s stock.